Why do most skincare factories fail at single-dose production?
Direct Answer
Most skincare factories fail at single-dose production because they lack the required equipment systems, aseptic control environments, and packaging compatibility needed for precise unit-dose manufacturing. Single-dose production requires a higher level of process control than traditional OEM skincare manufacturing, which many factories are not designed to support.
Why this happens
Single-dose production is structurally different from standard cosmetic manufacturing. It requires high-precision filling systems, strict contamination control, and individual unit sealing capability.
Many factories are optimized for bulk production, not isolated unit control.
Manufacturing Insight
Failure usually comes from three system gaps.
Equipment Gap
Lack of ampoule, BFS, or micro-dose filling systems.
Process Control Gap
Insufficient aseptic or cleanroom-grade control.
Packaging System Gap
Inability to handle sealed single-unit structures reliably.
Decision System Link
What this means in manufacturing decisions
Single-dose production failure is typically a capability mismatch issue rather than a formulation issue. This must be evaluated during early manufacturing feasibility assessment to avoid production breakdown at scale-up stage.